Welcome to our dedicated page for Ventas SEC filings (Ticker: VTR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ventas, Inc. filings document the regulatory record of a healthcare real estate investment trust whose common stock trades on the New York Stock Exchange under VTR. The company’s disclosures include Form 8-K reports for operating results, quarterly and annual earnings releases, dividend-related events, material financing agreements and capital markets activity.
Recent filings also cover amendments to credit facilities, registered senior notes issued by Ventas Realty, Limited Partnership and guaranteed by Ventas, ATM sales agreement updates, officer-transition disclosures and proxy materials addressing director elections, executive compensation, shareholder voting matters and governance.
Ventas, Inc. director Rodriguez Joe Vasquez Jr. acquired 48.5130 shares of common stock on July 16, 2026, reported as units credited as dividend equivalents under the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program adopted under the 2022 Incentive Plan. The grant was valued at $95.0400 per share, the closing price on the grant date, and is payable solely in common stock subject to the director's deferral election and program terms. Following this award, the director directly holds 9943.2320 shares of Ventas common stock. The Rule 10b5-1 trading plan checkbox was not marked for this transaction.
Ventas, Inc. director Matthew J. Lustig reported automatic stock-based awards tied to dividend equivalents. On July 16, 2026 he acquired 209.667 common-stock units under the Non-Employee Directors' Cash Compensation Deferral Plan and 71.615 units under the Equity Award Deferral Program, both valued at $95.04 per share, bringing his direct holdings to 95,734.706 shares payable solely in common stock.
EMBLER MICHAEL J reported acquisition or exercise transactions in this Form 4 filing.
Ventas director Michael J. Embler received a grant of 71.6150 common stock units on July 16, 2026, as dividend equivalents under the Non-Employee Directors' Equity Award Deferral Program adopted under the 2022 Incentive Plan. These units are payable solely in common stock and are reported at the $95.0400 closing price per share on the grant date, increasing his direct holdings to 19273.5730 shares.
Ventas, Inc. director Melody C. Barnes acquired 71.615 common-stock units on July 16, 2026, as a grant under the Non-Employee Directors' Equity Award Deferral Program, reflecting dividend equivalents on that date’s dividend. The award, valued at the $95.04 closing price per share, increases her direct holdings to 35,378.573 shares.
Martino Roxanne M reported acquisition or exercise transactions in this Form 4 filing.
Ventas, Inc. director Roxanne M. Martino reported receiving an award of 543.781 shares of common stock in the form of units under the company’s Non-Employee Directors' Cash Compensation Deferral Plan. The award reflects a value based on a closing price of $89.65 per share on the grant date.
These units were granted in lieu of cash director fees, pursuant to her deferral election, and are payable solely in common stock under the terms of the plan and her election. Following this grant, she holds a total of 66,671.802 shares of Ventas common stock directly.
Smith Maurice S reported acquisition or exercise transactions in this Form 4 filing.
Ventas, Inc. director Maurice S. Smith received an award of 460.889 shares of common stock, valued at $89.65 per share, as part of his director compensation. The award was granted in the form of units under the company’s Non-Employee Directors' Cash Compensation Deferral Plan in lieu of cash fees and is payable solely in common stock. After this grant, he directly holds a total of 31,183.56 shares of Ventas common stock.
LUSTIG MATTHEW J reported acquisition or exercise transactions in this Form 4 filing.
Ventas, Inc. director Matthew J. Lustig received an award of 447.712 common-stock-denominated units at a reference price of $89.65 per share. The award was made under Ventas’ Non-Employee Directors' Cash Compensation Deferral Plan in lieu of cash director fees and is payable solely in common stock. Following this grant, Lustig directly holds 95,453.424 shares of Ventas common stock.
Ventas, Inc. director Roy Sumit received a small equity award in the form of common stock units under the company’s Non-Employee Directors' Cash Compensation Deferral Plan. The award covered 348.578 shares of common stock, valued at the $89.65 closing price on the grant date. After this compensation-related acquisition, Sumit directly holds 24,752.802 shares of Ventas common stock. The transaction reflects director fees taken in stock rather than cash, not an open-market purchase.
Ventas, Inc. reported a leadership change in its legal department. Executive Vice President, General Counsel, Ethics & Compliance Officer and Corporate Secretary Carey S. Roberts has notified the company that she intends to resign effective June 26, 2026 to join Blackstone, Inc. as Senior Managing Director and General Counsel – Real Estate.
Through the effective date, Ms. Roberts will continue in her current role. As of that same date, Kevin M. Bohl, currently Senior Vice President, Deputy General Counsel and Assistant Corporate Secretary who has been with Ventas since 2011, will assume responsibilities as General Counsel, Ethics & Compliance Officer and Corporate Secretary on an interim basis.
Ventas, Inc. director Michael J. Embler reported an open-market purchase of 2,500 shares of the company’s Common Stock. The shares were bought at an average price of $78.81 per share. Following this transaction, he directly owns a total of 19,201.958 Ventas shares.